Stockscreener 앱 받기
13.46
3.04%
0.316
전일 마감가:
$13.14
열려 있는:
$13.07
하루 거래량:
55,290
Relative Volume:
0.47
시가총액:
$590.17M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-11.21%
1개월 성능:
-10.03%
6개월 성능:
+8.58%
1년 성능:
+0.00%
1일 변동 폭
$13.07
$13.86
1주일 범위
$12.89
$15.85
52주 변동 폭
$6.71
$18.67
Maze Therapeutics Inc Stock (MAZE) Company Profile
명칭
Maze Therapeutics Inc
전화
(650) 850-5070
주소
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
MAZE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MAZE
Maze Therapeutics Inc
|
13.47 | 624.11M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.27 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.41 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
439.33 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
633.79 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
286.90 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-23 | 개시 | H.C. Wainwright | Buy |
| 2025-07-08 | 개시 | Wedbush | Outperform |
Maze Therapeutics Inc 주식(MAZE)의 최신 뉴스
Why Maze Therapeutics Inc. stock attracts strong analyst attentionAI Trade Signal Forecast with Chart Logic - Newser
Is it time to cut losses on Maze Therapeutics Inc.Free Entry and Exit Strategy Optimizer Tool - Newser
Using data models to predict Maze Therapeutics Inc. stock movementAI-Based Stock Behavior Forecast Engine - Newser
What moving averages say about Maze Therapeutics Inc.Profit Target Planning with Exit Confidence - Newser
When is the best time to exit Maze Therapeutics Inc.Day Trading Setup Forecast with Trend Model - Newser
How to build a custom watchlist for Maze Therapeutics Inc.Real Market Tracker with Price Action Tools - Newser
What’s the recovery path for long term holders of Maze Therapeutics Inc.AI Driven Swing Trade Forecasting Insight - Newser
What makes Maze Therapeutics Inc. stock price move sharplyStock Entry Point Planner with Volume Spike - Newser
Visual trend scoring systems applied to Maze Therapeutics Inc.Portfolio Risk Distribution Analysis Tool - Newser
Real time pattern detection on Maze Therapeutics Inc. stockFree Risk-Adjusted Picks With Exit Strategy - Newser
Will a bounce in Maze Therapeutics Inc. offer an exitInvestment Roadmap for High Potential Stocks - Newser
How Maze Therapeutics Inc. stock performs during market volatilityTrade Setup Builder with Custom Alerts - Newser
Bank of New York Mellon Corp Makes New Investment in Maze Therapeutics, Inc. (NASDAQ:MAZE) - Defense World
Maze Therapeutics, Inc. (NASDAQ:MAZE) Receives $25.60 Average Price Target from Analysts - Defense World
How does Maze Therapeutics Inc. compare to its industry peersFast-track wealth growth - Jammu Links News
What are the technical indicators suggesting about Maze Therapeutics Inc.Invest confidently with real-time market updates - Jammu Links News
How volatile is Maze Therapeutics Inc. stock compared to the marketDiscover top stock picks for aggressive growth - Jammu Links News
What institutional investors are buying Maze Therapeutics Inc. stockFree Stock Market Forecast Reports - Jammu Links News
What are analysts’ price targets for Maze Therapeutics Inc. in the next 12 monthsInvest confidently with advanced analysis tools - Jammu Links News
What drives Maze Therapeutics Inc. stock priceCapitalize on emerging market opportunities - Jammu Links News
Is Maze Therapeutics Inc. a growth stock or a value stockBuild wealth steadily with proven stock picks - Jammu Links News
Is Maze Therapeutics Inc. stock overvalued or undervaluedUnlock exclusive stock market insights - Jammu Links News
Is Maze Therapeutics Inc. stock poised for growthFree Alpha Driven Watchlist With Alerts - Newser
Why is Maze Therapeutics Inc. stock attracting strong analyst attentionUnmatched profit potential - Jammu Links News
What are the latest earnings results for Maze Therapeutics Inc.High-profit capital plays - Jammu Links News
What is Maze Therapeutics Inc. company’s growth strategyWealth Building Planner With Proven Results - jammulinksnews.com
How to escape a deep drawdown in Maze Therapeutics Inc.Trade Safety Matrix for Conservative Traders - Newser
Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (SAGE) and ZimVie Inc (ZIMV) - The Globe and Mail
What to do if you’re stuck in Maze Therapeutics Inc.Quarterly Investment Outlook and Key Summary - Newser
Institutional scanner results for Maze Therapeutics Inc.Free Capital Efficiency Optimized Stock Alerts - Newser
A Note On Maze Therapeutics, Inc.'s (NASDAQ:MAZE) ROE and Debt To Equity - simplywall.st
Maze Therapeutics' 18% ROE: A Comprehensive Analysis - AInvest
Maze Therapeutics, Inc. (NASDAQ:MAZE) Has A ROE Of 18% - Yahoo Finance
Buy Signal for Maze Therapeutics Inc. Stock Key Technical Indicators to WatchSmart Risk Entry Zone Technical Analysis - Newser
Maze Therapeutics Inc (MAZE) 재무 분석
Maze Therapeutics Inc (MAZE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.88%
0.52%
자본화:
|
볼륨(24시간):